Sunday, June 21
9:15 AM - 9:45 AM | Product Theater | Alnylam Pharmaceuticals
How OXLUMO Makes a Difference: Clinical Data and Real Patient Cases
Examine OXLUMO's efficacy and safety data and explore how these findings may inform clinical decision-making. This session features practical insights from 2 real patient case reports, highlighting how OXLUMO may be used across different patient presentations and care settings
Speaker:
- Tarek Alhamad MD, MSPH, MBA
3:00 PM - 3:30 PM | Product Theater | Biogen
A Treatment for Two Rare Glomerular Diseases: C3G and Primary IC-MPGN
The session will provide an in-depth look at a treatment option for C3G and primary IC-MPGN, including disease education, mechanism of action, efficacy, safety, dosing and administration, and available patient support resources. The symposium will also highlight clinical trial data in transplant patient populations.
Speaker:
- Prince Mohan Anand, MD, FACP | Director of Transplant Services and Program Medical Director MUSC Health